Publication | Open Access
Survival outcomes of hepatic resection compared with transarterial chemoembolization or sorafenib for hepatocellular carcinoma with portal vein tumor thrombosis
105
Citations
19
References
2016
Year
Compared with TACE or sorafenib, HR may prolong the survival of patients with HCC in cases of CTP class A, type I PVTT or unilobar-involved HCC.
| Year | Citations | |
|---|---|---|
Page 1
Page 1